CRISPR will save lives - and technology can't come soon

New Post Public Reply Private Reply Replies (0) Message Board
wowhappens28
247
CRISPR will save lives - and technology can't come soon enough

This spooks me, but but big money could be made here, CRISPER stocks I will post later.

https://www.smh.com.au/technology/crispr-will...4z1n3.html

Humans have been tinkering with genes for as long we know. It’s why we have edible bananas instead of bulbous things with hard seeds, or corn that looks like corn and not grass. Well before the discovery of the gene, we’ve been breeding them in and out of plants and animals with absolutely no way of knowing what our introduced modifications do, where they end up in the genome, or how they might affect the environment.
Here’s the paradox: modern gene technology is far less genetically invasive – and much better understood – than the time-worn practice of selective breeding, and yet so many of us live in fear of genetically modified organisms. Instead of adding, removing, or reshuffling thousands of unknown genes in order to breed traits in or out of organisms, we’re now able to act on just one well-characterised gene with precision.
We didn’t need high-powered biotech to create dachshunds or bulldogs from ancestral wolves. The same breeding techniques that gave us virtually all of the food we now eat also has given our companions a predisposition to spinal problems and breathing difficulties.
Sinister. But short of us reverting to cave-dwellers, there really is no way out of it. Even kale, the staple crop of the inner city, started off as a weed.
Selective breeding is the cornerstone of agriculture, and civilisation might never have emerged without it. But compared with molecular methods, it’s like driving in a screw with a sledgehammer.
Enter CRISPR. This is a promising new gene editing technology that promises greater affordability and precision than ever before. It works by cutting through the DNA at a specific point, like a pair of molecular scissors. By taking advantage of the cell’s own DNA repair mechanisms, we’re able to insert, edit, or delete genes, in some cases down to a single unit of genetic code.
The potential applications of CRISPR are enormous. It’s the closest we’ve ever come to a cure for cancer. We’ve already been able to cure HIV infection in animal models, and even in human cell cultures, by removing the viral genes that insert themselves into our DNA. Incurable genetic diseases, like Duchenne’s muscular dystrophy, could soon be a thing of the past. CRISPR has already been used to cure the disease in rats.
But some are not so convinced. Couldn’t this technology be used to create a dystopia where only the rich can afford genetic enhancements to make themselves better, faster, stronger?

The short and long answer is no. There are limits to gene technology. When progressives shun gene technology for fear of creating a race of artificial super-humans, they unknowingly surrender to dangerous and discredited ideas that reek of the same eugenics they want to combat.
There are no “superior” genes, and therefore no way to create genetically superior humans. There are only genes that confer a selective advantage in a specific environment. Because I have darker skin, I’m less likely to develop melanoma. I’ve never even experienced sunburn. My skin colour is advantageous in sunny Australia, but not so useful in Scandinavia, where I could end up with a vitamin D deficiency.
Only a few traits are decisively linked to a single gene, like some types of red-green colourblindness (which, by the way, makes you better at seeing camouflage). But there’s no single genetic switch for abstract traits like intelligence or sexuality.

Even though there are a few dozen genes that are thought to contribute to intelligence, none of them do so in any way significant enough for us to modify. At best they contribute to a slightly increased probability, not a guarantee, that someone will be smarter. Some of them are also associated with schizophrenia, Alzheimer’s, and even obesity. Can you really call these genes superior? You’d be far better off getting a library membership.
Our genome is a biological balancing act, reliant on what is more advantageous to our survival. Even disease genes can be advantageous in certain environments. People with one copy of the sickle-cell disease gene, which causes a red blood cell deformity, are protected against malaria. This is largely why natural selection has not already created a race of super-humans. We are all born equal parts gifted and cursed.
Precisely because of this, CRISPR doesn’t even require us to insert any new genes at all for it to deliver. The chemical responsible for the browning of avocadoes is useful for the plant in the wild, but not so much when grown for agriculture. The same goes for allergens in nuts. With CRISPR, we can turn those genes off with minimal disruption to the genome.
It’s worth pointing out these gene deactivations crop up in nature all the time without any human intervention. A single genetic event was all it took to turn bitter almonds, containing lethal levels of cyanide, into the sweet variety we all love and enjoy.
The future of gene technology is a matter of public importance. CRISPR could revolutionise medicine and agriculture, but we still have a mountain to climb before we can put it to use. While we don’t think that there is a straightforward correspondence between genes and things like musical ability, we do think that such technology will have the potential to change things like hair, eye, and even skin colour. Where we should draw the line is up for debate. But one thing is clear: we need gene technology on our side.
It will be some time before we can say for certain that the technology is without side-effects, and even then there are challenges in getting the CRISPR mechanism into living cells. We’re getting there. But for some, the technology could not come soon enough. CRISPR will save lives.
Fahad Ali is a geneticist and member of the Sydney Nano Institute and the Sydney Institute of Agriculture. He works in developing novel delivery methods for the CRISPR mechanism in plant cells.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Saltwater Intrusion Spurs Key Concrete Strategy in Florida

Updated Category News Views 9

Water and concrete—two things that don't necessarily blend well in the realm of construction, right? Well, not unless you've got a trick up your sleeve like the folks at Provident Place in Pompano Beach, Florida. Facing the ever-looming threat of saltwater invasion, this little slice of Florida town is giving us a masterclass in protecting structures underwater. Why...

Continue Reading
Tide Rock Snags Electro-Spec: Big Moves in Industrial Plating

Updated Category News Views 6

Tide Rock Dives Deeper into Surface Finishing Here's the scoop: Tide Rock is getting serious about its ambitions in the specialty manufacturing scene, having scooped up Electro-Spec, one helluva player in the plating and surface finishing domain. This acquisition isn't just another notch in Tide Rock’s belt—it's a calculated move to fortify their position in a game...

Continue Reading
Shrieve Chemicals Expands Reach with RSG Acquisition

Updated Category News Views 3

Charting a New Course with an Acquisition Here we go again with another business shuffle—Shrieve Chemical Company has snatched up Research Solutions Group. What's cooking here is a classic recipe of expansion and strategic positioning. If you’re not familiar with Shrieve, they’re a big player in the global distribution of specialized chemicals. They've teamed up...

Continue Reading
EverSmith Rolls Out Training Hub to Propel Franchise Growth

Updated Category News Views 1

Big Ambitions Nestled in Milford, Ohio Beneath the glow of fluorescent lights in a fresh-to-the-world 12,000-square-foot box of opportunity, EverSmith Brands is betting on big returns. EverHUB has opened its doors, aiming to be the cradle that hatches their aggressive franchise dreams into reality. It's not just brick and mortar—it’s the manifestation of their grand...

Continue Reading
DaVita's Stand on HHS Kidney Plan: Innovation at Core

Updated Category News Views 8

DaVita Stands Firm on Kidney Care Innovation The healthcare landscape's shifting undercurrent, folks, and kidney care has landed smack in the spotlight with the U.S. Department of Health and Human Services (HHS) putting forth its Kidney Care National Plan. Now, this isn't some bureaucratic mumbo-jumbo—this plan's setting the tone for kidney disease treatment across...

Continue Reading
Samsung Biologics' Big Gains and Ambitious Moves in 2026

Updated Category News Views 6

A Robust Third Quarter Samsung Biologics is making some serious noise in the biopharma sector with its latest Q3 2026 financial results. We're talking about KRW 1,490 billion in revenue, an uptick that screams growth, backed by an operating profit of KRW 640 billion. What's fueling this engine? Their relentless plant expansion and a pivotal step into the U.S. market....

Continue Reading
Gildan Faces Heat: Channel Stuffing Allegations Arise

Updated Category News Views 8

Gildan's Stocks Take a Dive Amid Allegations Just when you thought the market swings were calming down, Gildan Activewear Inc. (NYSE: GIL) lands in hot water, sending investors scrambling. The spotlight's on them, thanks to some eye-catching accusations from Jehoshaphat Research. The word on the street is Gildan's been engaging in some questionable financial gymnastics...

Continue Reading
Harry Ritchie's Marks 70th Anniversary with Charity Event

Updated Category News Views 6

You don't sniff 70 years in retail without sewing some sturdy community threads. Harry Ritchie's, a stalwart in Eugene, Oregon's retail scene, just pulled a classic move: celebrating their seven-decade milestone by feeding folks instead of throwing a gala. In a world where local shops often vanish like ghosts, they're sticking with the founder's mantra from 1956: Be...

Continue Reading
AI Platform Revolutionizes Campus Career Services

Updated Category News Views 6

Reinventing the Campus Job Connection Technological tides are sweeping through universities like a gale force wind, shaking up the job-seeker game for students. Rollie Jobs is at the helm of this tech evolution, flexing its AI-powered muscles to revamp how career services function. The brainy folks behind Rollie Jobs are crafting a smoother bridge between textbooks and...

Continue Reading
Veteran Executive Joins Slayton Search: Key Insights

Updated Category News Views 1

There's a New Needle-Mover at Slayton Search: Karen Ouchterloney Straight off the bat, let's talk about the fresh blood Slayton Search Partners just brought into the fold. Karen Ouchterloney isn't just another name in the consumer industry—she's a heavyweight contender with over 30 years under her belt, making her appointment as Vice President & Managing Principal a...

Continue Reading

Top 5 Most Recently Viewed Articles

Navigating Global Payments: Insights for Investors Ahead

Updated Category News Views 175

Understanding Global Payments Stock Movements Global Payments (NYSE: GPN) finds itself at a crucial juncture as it navigates the final stages of a complex trading cycle. While the stock has been through significant phases in its recent history, investors should approach with caution considering the overall market sentiment and stock performance. This article delves into...

Continue Reading
FORG Introduces Innovative Wealth Management Solutions

Updated Category News Views 92

FORG Launches Comprehensive Wealth Management Solutions Family Office Resource Group (FORG) is set to transform the wealth management landscape with its innovative and comprehensive solutions for wealth management and professional service firms. By offering a white-labeled approach, FORG empowers firms to enhance their service delivery and support ultra-high-net-worth...

Continue Reading
abrdn Global Income Fund, Inc. Updates Investors on Proxy Status

Updated Category News Views 219

Insights into the Proxy Review Process for FCO abrdn Global Income Fund, Inc. (NYSE: FCO) has recently provided a vital update regarding its proxy and registration statement, which is currently undergoing review. This process is crucial as the fund prepares for a proposed reorganization into abrdn Asia-Pacific Income Fund, Inc. (NYSE: FAX). Understanding the elements at...

Continue Reading
Lantheus Holdings Faces Lawsuit Over Securities Violations

Updated Category News Views 121

Understanding the Lawsuit Against Lantheus Holdings, Inc. Lantheus Holdings, Inc. (NASDAQ: LNTH) is currently facing a significant class action lawsuit that is particularly relevant for shareholders. This legal action involves accusations related to violations of securities laws, specifically concerning misleading statements made to investors. Details of the Class Action...

Continue Reading
Exciting New Entertainment Experience Unveiled in Oklahoma

Updated Category News Views 183

Discover the Revamped Dave & Buster's in Oklahoma City It's time to grab your friends and family and head to the all-new Dave & Buster's! This exciting entertainment destination is opening its doors in Oklahoma City, inviting everyone to experience cutting-edge gaming and delicious dining. A Revolution in Entertainment The completely reimagined Dave & Buster's location...

Continue Reading